Symmetry Investments’s Eli Lilly LLY Stock Holding History

Symmetry Investments’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,560	Closed	-$11.4M	–	169
2024 Q2	$11.4M	Buy	+12,560	New	+$10M	1.27%	19

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Symmetry Investments's LLY Position: Q3 2024 in Review

Symmetry Investments sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 12,560 shares — an estimated $11.4M sold.

Symmetry Investments first reported a position in LLY in Q2 2024 and held it in 1 quarter. The position peaked at $11.4M in Q2 2024. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

Symmetry Investments reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
Symmetry Investments sold 12,560 Eli Lilly shares in Q3 2024, an estimated $11.4M.
Symmetry Investments first reported a position in Eli Lilly in Q2 2024 and held it in 1 quarter.
Symmetry Investments's Eli Lilly position peaked at $11.4M in Q2 2024.
3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Symmetry Investments's 13F filing for Q3 2024, filed 14 Nov 2024.